Serum Concentrations of Insulin, Ghrelin, Adiponectin, Leptin, Leptin Receptor and Lipocalin-2 in Children with Celiac Disease Who Do and Do Not Adhere to a Gluten-Free Diet
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The roles of the many bioactive peptides in the pathogenesis of celiac disease remain unclear. To evaluate the serum concentrations of insulin, ghrelin, adiponectin, leptin, leptin receptor, and lipocalin-2 in children with celiac disease who do and do not adhere to a gluten-free diet (GFD, intermittent adherence). Methods: Prepubertal, pubertal, and adolescent celiac children were included in this study (74 girls and 53 boys on a GFD and 80 girls and 40 boys off of a GFD). Results: Insulin levels in prepubertal (9.01±4.43 μIU/mL), pubertal (10.3±3.62 μIU/mL), and adolescent (10.8±4.73 μIU/mL) girls were higher than those in boys (5.88±2.02, 8.81±2.88, and 8.81±2.26 μIU/mL, respectively) and were neither age-dependent nor influenced by a GFD. Prepubertal children off of a GFD exhibited higher ghrelin levels than prepubertal children on a GFD. Adiponectin levels were not age-, sex- nor GFD-dependent. Adherence to a GFD had no effect on the expression of leptin, leptin receptor, and lipocalin-2. Conclusions: Adherence to a GFD had no influence on the adiponectin, leptin, leptin receptor, and lipocalin-2 concentrations in celiac children, but a GFD decreased highly elevated ghrelin levels in prepubertal children. Further studies are required to determine whether increased insulin concentrations in girls with celiac disease is suggestive of an increased risk for hyperinsulinemia.
Abstract
Background/Aims: The roles of the many bioactive peptides in the pathogenesis of celiac disease remain unclear. To evaluate the serum concentrations of insulin, ghrelin, adiponectin, leptin, leptin receptor, and lipocalin-2 in children with celiac disease who do and do not adhere to a gluten-free diet (GFD, intermittent adherence). Methods: Prepubertal, pubertal, and adolescent celiac children were included in this study (74 girls and 53 boys on a GFD and 80 girls and 40 boys off of a GFD). Results: Insulin levels in prepubertal (9.01±4.43 μIU/mL), pubertal (10.3±3.62 μIU/mL), and adolescent (10.8±4.73 μIU/mL) girls were higher than those in boys (5.88±2.02, 8.81±2.88, and 8.81±2.26 μIU/mL, respectively) and were neither age-dependent nor influenced by a GFD. Prepubertal children off of a GFD exhibited higher ghrelin levels than prepubertal children on a GFD. Adiponectin levels were not age-, sex- nor GFD-dependent. Adherence to a GFD had no effect on the expression of leptin, leptin receptor, and lipocalin-2. Conclusions: Adherence to a GFD had no influence on the adiponectin, leptin, leptin receptor, and lipocalin-2 concentrations in celiac children, but a GFD decreased highly elevated ghrelin levels in prepubertal children. Further studies are required to determine whether increased insulin concentrations in girls with celiac disease is suggestive of an increased risk for hyperinsulinemia.
참고문헌 (46)
- Green PH, "Celiac disease", N Engl J Med, 357, pp.1731~1743 (2007)
- Guandalini S, "Celiac disease: a review", JAMA Pediatr, 168, pp.272~278 (2014)
- Hill ID, "Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition", J Pediatr Gastroenterol Nutr, 40, pp.1~19 (2005)
- Husby S, "European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease", J Pediatr Gastroenterol Nutr, 54, pp.136~160 (2012)
- McGowan KE, "The changing face of childhood celiac disease in North America: impact of serological testing", Pediatrics, 124, pp.1572~1578 (2009)
- Brambilla P, "Changes of body mass index in celiac children on a gluten-free diet", Nutr Metab Cardiovasc Dis, 23, pp.177~182 (2013)
- Tucker E, "Patients with coeliac disease are increasingly overweight or obese on presentation", J Gastrointestin Liver Dis, 21, pp.11~15 (2012)
- Wieser H, "The biochemical basis of celiac disease", Cereal Chem, 85, pp.1~13 (2008)
- Garrote JA, "Celiac disease pathogenesis: the proinflammatory cytokine network", J Pediatr Gastroenterol Nutr, 47(1), pp.S27~S32 (2008)
- Boguszewski MC, "Celiac disease, short stature and growth hormone deficiency", Transl Gastrointest Cancer, 4, pp.69~75 (2015)
- Gujral N, "Celiac disease: prevalence, diagnosis, pathogenesis and treatment", World J Gastroenterol, 18, pp.6036~6059 (2012)
- Spatola BN, "Persistence of elevated deamidated gliadin peptide antibodies on a gluten-free diet indicates nonresponsive coeliac disease", Aliment Pharmacol Ther, 39, pp.407~417 (2014)
- Oberhuber G, "The histopathology of coeliac disease: time for a standardized report scheme for pathologists", Eur J Gastroenterol Hepatol, 11, pp.1185~1194 (1999)
- Kabbani TA, "Patients with celiac disease have a lower prevalence of non-insulin-dependent diabetes mellitus and metabolic syndrome", Gastroenterology, 144(e1), pp.912~917 (2013)
- Tortora R, "Metabolic syndrome in patients with coeliac disease on a gluten-free diet", Aliment Pharmacol Ther, 41, pp.352~359 (2015)
- Valentini L, "Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease", Nutrition, 25, pp.172~181 (2009)
- Bregenzer N, "Increased insulin resistance and beta cell activity in patients with Crohn’s disease", Inflamm Bowel Dis, 12, pp.53~56 (2006)
- Lanzini A, "Circulating ghrelin level is increased in coeliac disease as in functional dyspepsia and reverts to normal during gluten-free diet", Aliment Pharmacol Ther, 23, pp.907~913 (2006)
- Capristo E, "Reduced plasma ghrelin concentration in celiac disease after gluten-free diet treatment", Scand J Gastroenterol, 40, pp.430~436 (2005)
- Peracchi M, "Circulating ghrelin levels in celiac patients", Am J Gastroenterol, 98, pp.2474~2478 (2003)
- Selimoglu MA, "Serum ghrelin levels in children with celiac disease", J Clin Gastroenterol, 40, pp.191~194 (2006)
- Kempiński R, "Plasma ghrelin concentration in celiac patients", Gastroenterol Pol, 15, pp.375~377 (2008)
- Tomasik PJ, "The orexigenic peptides in children with celiac disease", J Appl Res, 9, pp.70~75 (2009)
- Karmiris K, "Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease", Inflamm Bowel Dis, 12, pp.100~105 (2006)
- Karmiris K, "Leptin, adiponectin, resistin, and ghrelin: implications for inflammatory bowel disease", Mol Nutr Food Res, 52, pp.855~866 (2008)
- Deboer MD, "Use of ghrelin as a treatment for inflammatory bowel disease: mechanistic considerations", Int J Pept, 2011, pp.189242~ (2011)
- Manavalan JS, "Serum cytokine elevations in celiac disease: association with disease presentation", Hum Immunol, 71, pp.50~57 (2010)
- Jarocka-Cyrta E, "The ghrelin-positive cells number is increased in duodenum in children with celiac disease", J Endocrinol Invest, 33, pp.165~170 (2010)
- Russo F, "Adipokine profile in celiac patients: differences in comparison with patients suffering from diarrhea-predominant IBS and healthy subjects", Scand J Gastroenterol, 48, pp.1377~1385 (2013)
- Shetty S, "Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies", Trends Pharmacol Sci, 30, pp.234~239 (2009)
- Batra A, "Adipokine signaling in inflammatory bowel disease", Inflamm Bowel Dis, 15, pp.1897~1905 (2009)
- Weigert J, "Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn’s disease", Inflamm Bowel Dis, 16, pp.630~637 (2010)
- Paul G, "Profiling adipocytokine secretion from creeping fat in Crohn’s disease", Inflamm Bowel Dis, 12, pp.471~477 (2006)
- Herfarth HH, "Prevalence of a gluten-free diet and improvement of clinical symptoms in patients with inflammatory bowel diseases", Inflamm Bowel Dis, 20, pp.1194~1197 (2014)
- Waluga M, "Serum adipokines in inflammatory bowel disease", World J Gastroenterol, 20, pp.6912~6917 (2014)
- Bolignano D, "Neutrophil gelatinase-associated lipocalin levels in patients with Crohn’s disease undergoing treatment with infliximab", J Investig Med, 58, pp.569~571 (2010)
- Chan JL, "Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans", Diabetes, 51, pp.2105~2112 (2002)
- Kratzsch J, "Circulating soluble leptin receptor and free leptin index during childhood, puberty, and adolescence", J Clin Endocrinol Metab, 87, pp.4587~4594 (2002)
- Ertekin V, "Serum leptin levels in childhood celiac disease", J Clin Gastroenterol, 40, pp.906~909 (2006)
- Maggio MC, "Gluten-free diet impact on leptin levels in asymptomatic coeliac adolescents: one year of follow-up", Horm Res, 67, pp.100~104 (2007)
- Aurangzeb B, "Assessment of nutritional status and serum leptin in children with inflammatory bowel disease", J Pediatr Gastroenterol Nutr, 52, pp.536~541 (2011)
- Jönsson T, "Digested wheat gluten inhibits binding between leptin and its receptor", BMC Biochem, 16, pp.3~ (2015)
- Ockenga J, "Distinct roles of free leptin, bound leptin and soluble leptin receptor during the metabolic-inflammatory response in patients with liver cirrhosis", Aliment Pharmacol Ther, 25, pp.1301~1309 (2007)
- Singer E, "Neutrophil gelatinase-associated lipocalin: pathophysiology and clinical applications", Acta Physiol, 207, pp.663~672 (2013)
- Janas RM, "Neutrophil gelatinaseassociated lipocalin in blood in children with inflammatory bowel disease", J Gastroenterol Hepato, 29, pp.1883~1889 (2014)
- Oikonomou KA, "Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity", J Gastroenterol, 47, pp.519~530 (2012)
